FIRST MERCANTILE TRUST CO - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 168 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST MERCANTILE TRUST CO ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$50,000
-37.5%
4,845
-0.7%
0.01%
-22.2%
Q4 2019$80,000
+21.2%
4,879
-1.6%
0.01%
+28.6%
Q3 2019$66,000
+4.8%
4,960
+11.6%
0.01%0.0%
Q2 2019$63,000
-21.2%
4,444
+1.9%
0.01%
-63.2%
Q1 2019$80,000
-40.3%
4,360
-14.7%
0.02%
-40.6%
Q4 2018$134,000
-2.9%
5,110
-14.8%
0.03%
+18.5%
Q3 2018$138,000
+0.7%
6,000
-16.6%
0.03%0.0%
Q2 2018$137,000
+18.1%
7,195
+4.9%
0.03%
+12.5%
Q1 2018$116,000
+11.5%
6,8600.0%0.02%
+20.0%
Q4 2017$104,000
-2.8%
6,860
+14.7%
0.02%
+5.3%
Q3 2017$107,000
+9.2%
5,980
-0.8%
0.02%
+5.6%
Q2 2017$98,000
+14.0%
6,030
-1.6%
0.02%
+38.5%
Q1 2017$86,000
-17.3%
6,130
-5.5%
0.01%
-18.8%
Q4 2016$104,000
-2.8%
6,490
+1.1%
0.02%
+14.3%
Q3 2016$107,000
+8.1%
6,420
-27.5%
0.01%
+16.7%
Q2 2016$99,000
+30.3%
8,860
-3.2%
0.01%
+33.3%
Q1 2016$76,000
-13.6%
9,150
-3.2%
0.01%0.0%
Q4 2015$88,000
-15.4%
9,450
+2.6%
0.01%
-10.0%
Q3 2015$104,000
+8.3%
9,210
+21.3%
0.01%
+25.0%
Q2 2015$96,000
+33.3%
7,590
-1.4%
0.01%
+33.3%
Q1 2015$72,000
+26.3%
7,700
+119.7%
0.01%
+20.0%
Q2 2014$57,0003,5050.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,532,000$27,423,0003.23%
Stonepine Capital Management, LLC 300,000$5,370,0003.16%
Palo Alto Investors LP 4,155,670$74,386,0003.13%
GREAT POINT PARTNERS LLC 497,531$8,906,0001.73%
Avoro Capital Advisors LLC 988,270$17,690,0001.37%
UNIVERSITY OF NOTRE DAME DU LAC 157,781$2,824,0000.79%
Birchview Capital, LP 68,000$1,217,0000.63%
Cheyne Capital Management (UK) LLP 74,000$1,323,0000.48%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 352,604$6,311,0000.43%
361 CAPITAL LLC 119,554$2,140,0000.41%
View complete list of VANDA PHARMACEUTICALS INC shareholders